Jan 20, 2010
New CEO
QuantiBact Inc. has chosen Mr. Palle Schelde as the CEO.
Palle Schelde has extensive commercial experience from within the biotechnology industry in both the CEO role as well as being partner in a venture capital fund with emphasis on life science.
Palle Schelde Holds a M.Sc. in molecular biochemistry. Besides working with research projects in the area of cancer and drug development, he has for 15 years worked within the pharmaceutical and diagnostic industry in the area of sales and marketing. He has a broad experience in several medical indication areas as well as a profound knowledge in diagnostics especially clinical microbiology and clinical genetics.